Literature DB >> 8576078

Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria.

M Hoshi1, M Sato, S Kondo, A Takashima, K Noguchi, M Takahashi, K Ishiguro, K Imahori.   

Abstract

We examined the subcellular distribution of two glycogen synthase kinase-3 (GSK-3) isoforms in rat cerebellum. Results from immunoelectron microscopy and subcellular fractionation revealed that one isoform, tau protein kinase I/GSK-3 beta (TPKI/GSK-3 beta), was present in mitochondria, but GSK-3 alpha was not. Although the two GSK-3 isoforms seem to have similar properties, the difference of subcellular localization observed here suggests that TPKI/GSK-3 beta fulfills some specific function in mitochondria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8576078     DOI: 10.1093/oxfordjournals.jbchem.a124965

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  22 in total

1.  Mitochondrial-targeted active Akt protects SH-SY5Y neuroblastoma cells from staurosporine-induced apoptotic cell death.

Authors:  Paramita Mookherjee; Rodrigo Quintanilla; Myoung-Sun Roh; Anna A Zmijewska; Richard S Jope; Gail V W Johnson
Journal:  J Cell Biochem       Date:  2007-09-01       Impact factor: 4.429

Review 2.  Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.

Authors:  Rosilla F Bachmann; Robert J Schloesser; Todd D Gould; Husseini K Manji
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

Review 3.  Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.

Authors:  Mahdi Rizk; Zahraa Saker; Hisham F Bahmad; Sanaa Nabha; Hayat Harati; Youssef Fares
Journal:  Mol Biol Rep       Date:  2021-03-01       Impact factor: 2.316

4.  Unregulated mitochondrial GSK3beta activity results in NADH: ubiquinone oxidoreductase deficiency.

Authors:  Taj D King; Buffie Clodfelder-Miller; Keri A Barksdale; Gautam N Bijur
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

5.  Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain.

Authors:  Emma Perez-Costas; Johanna C Gandy; Miguel Melendez-Ferro; Rosalinda C Roberts; Gautam N Bijur
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

6.  The nuclear localization of glycogen synthase kinase 3β is required its putative PY-nuclear localization sequences.

Authors:  Sung Hwa Shin; Eun Jeoung Lee; Jaesun Chun; Sunghee Hyun; Youg Il Kim; Sang Sun Kang
Journal:  Mol Cells       Date:  2012-10-18       Impact factor: 5.034

7.  Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease.

Authors:  Camila Teixeira Mendes; Fábio Borges Mury; Eloísa de Sá Moreira; Fernando Lopes Alberto; Orestes Vicente Forlenza; Emmanuel Dias-Neto; Wagner Farid Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-10-17       Impact factor: 5.270

8.  GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle.

Authors:  T P Ciaraldi; L Carter; S Mudaliar; R R Henry
Journal:  Mol Cell Endocrinol       Date:  2009-06-06       Impact factor: 4.102

9.  SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3β.

Authors:  Nagalingam R Sundaresan; Samik Bindu; Vinodkumar B Pillai; Sadhana Samant; Yong Pan; Jing-Yi Huang; Madhu Gupta; Raghu S Nagalingam; Donald Wolfgeher; Eric Verdin; Mahesh P Gupta
Journal:  Mol Cell Biol       Date:  2015-12-14       Impact factor: 4.272

10.  Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons.

Authors:  Agnès Petit-Paitel; Frédéric Brau; Julie Cazareth; Joëlle Chabry
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.